Literature DB >> 14766396

The immunophilin FKBP12: a molecular guardian of the TGF-beta family type I receptors.

Tongwen Wang1, Patricia K Donahoe.   

Abstract

FKBP12 as an immunophilin that binds to two well-known immunosuppressive macrolides, FK506 and rapamycin, has attracted immense attention and its role in mediating the immunosuppressive functions of these macrolides has been extensively studied. Since FKBP12 is a well-conserved protein among many species and is also highly expressed in almost all cells, it must play important roles in cellular function in the absence of macrolides. In one such a role, FKBP12 interacts with and regulates the functional state of the ryanodine Ca2+ channel receptor by altering protein conformation and coordinating multi-protein complex formation. This review summarizes another physiological role of FKBP12 as an interactor and a regulator of the type I serine/threonine kinase receptors of TGF-beta superfamily. Current data, derived from detailed biochemical studies as well as from functional studies in various systems, suggest that FKBP12 functions as a "guardian" for the type I receptors to prevent them from leaky signaling under sub-optimal ligand concentrations, thereby providing a molecular "gradient reader" for TGF-beta family morphogens. This aspect of FKBP12 function may be critical for cellular responsiveness to morphogenetic gradients of the TGF-beta family members during early development, serving to assure the translation of different ligand concentrations into different signaling readouts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766396     DOI: 10.2741/1095

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  27 in total

1.  FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.

Authors:  Valorie L Chiasson; Deepa Talreja; Kristina J Young; Piyali Chatterjee; Amy K Banes-Berceli; Brett M Mitchell
Journal:  Hypertension       Date:  2011-04-25       Impact factor: 10.190

2.  mTOR is the rapamycin-sensitive kinase that confers mechanically-induced phosphorylation of the hydrophobic motif site Thr(389) in p70(S6k).

Authors:  Troy Alan Hornberger; Kunal Balu Sukhija; Xiao-Rong Wang; Shu Chien
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124

3.  FKBPs and the Akt/mTOR pathway.

Authors:  Felix Hausch; Christian Kozany; Marily Theodoropoulou; Anne-Katrin Fabian
Journal:  Cell Cycle       Date:  2013-07-01       Impact factor: 4.534

4.  A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.

Authors:  Celia L Gregson; Peter Hollingworth; Martin Williams; Kirsten A Petrie; Alex N Bullock; Matthew A Brown; Jon H Tobias; James T Triffitt
Journal:  Bone       Date:  2010-10-29       Impact factor: 4.398

5.  The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth.

Authors:  Craig A Goodman; John W Frey; Danielle M Mabrey; Brittany L Jacobs; Hannah C Lincoln; Jae-Sung You; Troy A Hornberger
Journal:  J Physiol       Date:  2011-09-26       Impact factor: 5.182

Review 6.  Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass.

Authors:  Craig A Goodman; David L Mayhew; Troy A Hornberger
Journal:  Cell Signal       Date:  2011-07-23       Impact factor: 4.315

Review 7.  Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies.

Authors:  Jorge A Garcia; David Danielpour
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

8.  Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.

Authors:  Olaf Sunnotel; Laszlo Hiripi; Kevin Lagan; Jennifer R McDaid; Johanny M De León; Yasushi Miyagawa; Hannah Crowe; Soniya Kaluskar; Michael Ward; Catherine Scullion; Alan Campbell; C S Downes; David Hirst; David Barton; Edgar Mocanu; Akira Tsujimura; Marc B Cox; Tracy Robson; Colum P Walsh
Journal:  Reprod Biol Endocrinol       Date:  2010-03-08       Impact factor: 5.211

9.  A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.

Authors:  Craig A Goodman; Man Hing Miu; John W Frey; Danielle M Mabrey; Hannah C Lincoln; Yejing Ge; Jie Chen; Troy A Hornberger
Journal:  Mol Biol Cell       Date:  2010-07-28       Impact factor: 4.138

Review 10.  Granting immunity to FOP and catching heterotopic ossification in the Act.

Authors:  Frederick S Kaplan; Robert J Pignolo; Eileen M Shore
Journal:  Semin Cell Dev Biol       Date:  2015-12-17       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.